Navigation Links
Veracyte, Inc. Announces Third Quarter 2013 Financial Results
Date:11/25/2013

42-gene signature to determine pre-operatively whether thyroid nodules previously classified by cytopathology as indeterminate can be reclassified as benign. The clinical utility and cost effectiveness of the GEC have been demonstrated in studies published in peer-reviewed journals and the clinical validity of the GEC has been demonstrated in a study published in The New England Journal of Medicine in 2012. Since the commercial launch of Afirma in January 2011, Veracyte has received over 60,000 FNA samples for evaluation using Afirma and has performed approximately 12,000 GECs to resolve indeterminate cytopathology results. Veracyte has obtained positive coverage decisions for Afirma from Aetna, Humana, Medicare and UnitedHealthcare. Collectively, these payers represent more than 100 million covered lives. Afirma is marketed and sold in the United States through a global co-promotion agreement with Genzyme Corporation, a subsidiary of Sanofi. Veracyte estimates the global market for Afirma to be $800 million. The company intends to expand its molecular cytology franchise to other clinical areas and is in late biomarker discovery for its first product in pulmonology.

Veracyte and Afirma are trademarks of Veracyte, Inc. This press release also contains trademarks and trade names that are the property of their respective owners.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential benefits of the Afirma GEC to patients, physicians and payers; the company's belief that the proceeds from its IPO will enable it to accelerate its sales and marketing efforts; the company's belief that it is well-positioned to advance long-term growth; the ability of the company's test to change clinical outcomes; the potential of the Afirma GEC, supplemented by an additional gene set, to identify patients with MTC and
'/>"/>

SOURCE Veracyte
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Veracyte, Inc. to Announce Third Quarter 2013 Financial Results and Host Conference Call on Monday, November 25, 2013
2. Veracyte, Inc. Announces Pricing of Initial Public Offering
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Golden Meditech Announces 2013 / 2014 Interim Results
5. iHealth Announces Results of AHA Walking Challenge
6. Unilife Announces Results of 2013 Annual General Meeting
7. Hanger Announces Appointment of Christopher B. Begley to Board of Directors
8. CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013
9. Array BioPharma Announces Management Team Change
10. Hill-Rom Holdings, Inc. Announces First Quarter 2014 Dividend
11. Argos Therapeutics Announces Additional $17.5 Million Of Series E Financing Bringing Total Commitment To $60 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 Unchained Labs, a refreshingly new biologic ... PEGS conference and launches the UNit — the first ... The Essential Protein Engineering Summit takes place in ... The UNit lets drug discovery researchers look at more ... Its 7 applications, 144 sample a day throughput and ...
(Date:5/4/2015)... , May 4, 2015 The Pharmacy ... Survey, which confirmed that pharmacy has shifted toward a ... active pharmacists and managers, there is an incredible opportunity ... in the next decade. In a ... site, Essential Insights , Eden Sulzer, director ...
(Date:5/4/2015)... 4, 2015  Verus Healthcare, Inc. recently completed its ... Care Club in 2012.  Since that original acquisition, the ... medical equipment (DME) industry by 1,000%.  Verus Healthcare now ... supply needs and processes nearly 14,000 new orders per ... years ago, the systems and processes weren,t in place ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2
... Cyberonics, Inc. (Nasdaq: CYBX ) today announced ... Browne, Chief Financial Officer, will present at the 22nd Annual ... November 30, 2010 at 1:30 PM ET.  The conference session ... will be presented.  Piper Jaffray will host a webcast of ...
... /PRNewswire-FirstCall/ -- AVANIR ... the pricing of an underwritten public offering of 20,000,000 shares ... per share.  The offering is expected to close on or ... addition, AVANIR has granted the underwriters a 30-day option to ...
Cached Medicine Technology:Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference 2AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3
(Date:5/4/2015)... Sheltering Arms announced that it has acquired ... Mother Hale Learning Center meets a tremendous need in ... Arms will begin operating the site immediately and all ... center. , Opened in 2006, the Mother Hale Learning ... years, many of whom come from high-need backgrounds. Guided ...
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
(Date:5/4/2015)... Elisabeth Rosenthal’s article* on “balance ... showed the healthcare fraternity as well as patients ... downside of balance billing. In definition, balance billing ... a patient for the difference between what the ... the provider chooses to charge. Rosenthal’s article talks ...
(Date:5/4/2015)... 2015 In response to the ... Task Force (USPSTF), Strategic Radiology® (SR®) fully aligns ... Obstetricians and Gynecologists (ACOG), the American College Of ... Cancer Society (ACS), American College of Radiology (ACR), ... recommend regular screening mammography for women beginning at ...
(Date:5/4/2015)... World T.E.A.M. Sports’ best-attended Face of ... last decade arrived in this historic Civil War community ... from the Pentagon in Arlington, Virginia. The annual ride ... able-bodied participants work together to successfully complete the journey. ... commitment and sacrifices by military veterans in their defensive ...
Breaking Medicine News(10 mins):Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4
... a product containing the drug estazolam, which might make the ... // ,Estazolam belongs to benzodiazepines class of drugs, ... it may have a number of side effects like loss ... not legal to sell it in Canada. ,Hence, try ...
... There has been a major outbreak of pneumonia in the ... // ,The outbreak in the Downtown Eastside has ... month. ,In a November 30 memo, David Butcher, ... staff that the Vancouver outbreak was severely limiting the availability ...
... become an integral part of the cocktail of drugs consumed by ... ice are marijuana, ketamine, heroin and other illicit drugs. ,Ice ... when they have report to work. ,After excessive stimulation by ... which they usually smoke ice to get over it. ,Paul ...
... taken from primary tumor biopsies is highly associated with ... to researchers who// say this protein profile could help ... is likely to metastasize. ,In the December ... of one unidentified protein and under-expression of another is ...
... by team of senior scientists warns that many tests of drugs ... prototype medicine will work on humans. ,The British Medical ... have found that animal studies agreed with human trials in just ... that the high-profile London drug trial that left six men ill ...
... Health urges people with history of unprotected sex to ... local HIV transmission.// The announcement being the first case ... officials, on Thursday uncovered two clusters of HIV infections, ... samples by government scientists. They said that both the ...
Cached Medicine News:Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 2Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 3Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 4Health News:Many Drug Tests on Animals are Badly Flawed, a Study Warns 2
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
The cementless biomEx cup can be used with both cemented and cementless femoral stems....
The Secur-Fit cups incorporate enhancements derived from years of clinical, radiographic, and implant retrieval observations....
Medicine Products: